Rekvina Laboratories Limited (BOM:526075)
India · Delayed Price · Currency is INR 43.13
+0.84 (1.99%)
At close: Apr 17, 2026
Rekvina Laboratories Market Cap
Rekvina Laboratories has a market cap or net worth of 254.92 million as of April 17, 2026. Its market cap has increased by 737.43% in one year.
Market Cap
254.92M
Enterprise Value
263.03M
Revenue
5.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
43.13
Market Cap Chart
Since July 26, 2013, Rekvina Laboratories's market cap has decreased from 443.60M to 254.92M, a decrease of -42.53%. That is a compound annual growth rate of -4.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 254.92M | 839.78% |
| Dec 13, 2021 | 27.13M | 4.65% |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Walpar Nutritions | 396.75M |
| Sandu Pharmaceuticals | 367.02M |
| Murae Organisor | 353.20M |
| ANG Lifesciences India | 324.11M |
| JFL Life Sciences | 316.76M |
| Deccan Health Care | 288.60M |
| Gujarat Terce Laboratories | 258.75M |
| Cian Healthcare | 206.47M |